Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 281.00
+3.00 (1.08%)
Dec 5, 2025, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 18.77 billion as of December 5, 2025. Its market cap has increased by 84.87% in one year.
Market Cap
18.77B
Enterprise Value
16.44B
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
281.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 18.77B, an increase of 631.81%. That is a compound annual growth rate of 46.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 18.77B | 98.59% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | 2.79B | 8.89% |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Lin BioScience | 32.35B |
| Center Laboratories | 27.88B |